                               SEQUENCE LISTING	

<110> ENZON PHARMACEUTICALS, INC. 
      Hong ZHAO
      Weili YAN
      Lianjun SHI
      Maksim ROYZEN
      Dechun WU
 
<120> RELEASABLE CATIONIC LIPIDS FOR NUCLEIC ACIDS DELIVERY SYSTEMS

<130> 213.1309-PCT

<140>
<141>

<150> 61/115,287
<151> 2008-11-17

<150> 61/115,348
<151> 2008-11-17

<150> 61/115,365
<151> 2008-11-17

<160> 24   

<170> PatentIn version 3.5

<210> 1
<211> 16
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artifical Sequence:
      Synthetic oligonucleotide

<400> 1
ctcaatccat ggcagc                                            16    


<210> 2
<211> 21
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Combined DNA/RNA Molecule:
      Synthetic oligonucleotide

<220> 
<221> misc_feature
<222> (1)  (19)
<223> RNA

<400> 2
gcaugcggcc ucuguuugat t                                       21    


<210> 3
<211> 21
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Combined DNA/RNA Molecule:
      Synthetic oligonucleotide

<220> 
<221> misc_feature
<222> (1)  (19)
<223> RNA

<400> 3
ucaaacagag gccgcaugct t                                       21    


<210> 4
<211> 19
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artifical Sequence:
      Synthetic oligonucleotide

<400> 4
tctcccagcg tgcgcccat                                          19
 

<210> 5
<211> 16
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artifical Sequence:
      Synthetic oligonucleotide

<400> 5
tggcaagcat cctgta                                             16


<210> 6
<211> 16
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artifical Sequence:
      Synthetic oligonucleotide

<400> 6
tagcctgtca cttctc                                             16  


<210> 7
<211> 16
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artifical Sequence:
      Synthetic oligonucleotide

<400> 7
gctccagaca  tcactc					      16


<210> 8
<211> 16
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artifical Sequence:
      Synthetic oligonucleotide

<400> 8 
agccattcat  tccacc					      16

 

<210> 9
<211> 16
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artifical Sequence:
      Synthetic oligonucleotide

<400> 9	
ttattgtgca  tctcag				   	      16


<210> 10
<211> 16
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artifical Sequence:
      Synthetic oligonucleotide

<400> 10
cgtgtatttc  cgcgtg				   	      16


<210> 11
<211> 16
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artifical Sequence:
      Synthetic oligonucleotide

<400> 11
ggcacagcca  gtggcg					      16


<210> 12
<211> 16
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artifical Sequence:
      Synthetic oligonucleotide

<400> 12
cccaaggcac  tgcaga					      16


<210> 13
<211> 16
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artifical Sequence:
      Synthetic oligonucleotide

<400> 13
accaagtttc  ttcagc 					      16


<210> 14
<211> 16
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artifical Sequence:
      Synthetic oligonucleotide

<400> 14
ctccttggtg  cagtct					      16											

<210> 15
<211> 15
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artifical Sequence:
      Synthetic oligonucleotide

<400> 15
tcagattcaa  accca 					      15


<210>  16
<211>  16
<212>  DNA
<213>  Artificial sequence

<220> 
<223> Description of Artifical Sequence:
      Synthetic oligonucleotide

<400>  16
gtgttctaca  ccatta 					      16

<210>  17
<211>  12
<212>  PRT
<213>  Artificial sequence

<220> 
<223> Description of Artifical Sequence:
      Synthetic peptide

<400>  17
Cys Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg
1               5                   10  


<210>  18
<211>  10
<212>  PRT
<213>  Artificial sequence

<220> 
<223> Description of Artifical Sequence:
      Synthetic peptide

<400>  18
Cys Arg Arg Arg Arg Arg Arg Arg Arg Arg
1               5                   10  


<210>  19
<211>  23
<212>  PRT
<213>  Artificial sequence

<220> 
<223> Description of Artifical Sequence:
      Synthetic peptide

<400>  19
Cys Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Tyr Gly Arg Lys 
1               5                   10                  15         

Lys Arg Arg Gln Arg Arg Arg
            20 


<210>  20
<211>  4
<212>  PRT
<213>  Artificial sequence

<220> 
<223> Description of Artifical Sequence:
      Synthetic peptide

<400>  20
Arg Gly Asp Cys
1                                 


<210>  21
<211>  5
<212>  PRT
<213>  Artificial sequence

<220> 
<223> Description of Artifical Sequence:
      Synthetic peptide

<400>  21
Arg Gly Asp Phe Cys
1               5               


<210>  22
<211>  5
<212>  PRT
<213>  Artificial sequence

<220> 
<223> Description of Artifical Sequence:
      Synthetic peptide

<400>  22
Arg Gly Asp Phe Lys
1               5


<210>  23
<211>  19
<212>  PRT
<213>  Artificial sequence

<220> 
<223> Description of Artifical Sequence:
      Synthetic peptide

<400>  23
Cys Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Gly Gly Gly Arg 
1               5                   10                  15   

Gly Asp Ser


<210>  24
<211>  9
<212>  PRT
<213>  Artificial sequence

<220> 
<223> Description of Artifical Sequence:
      Synthetic peptide

<400>  24
Arg Arg Arg Arg Arg Arg Arg Arg Arg
1               5                                 










